This sector faced some serious headwinds in 2017, particularly in the form of regulatory overload from the Centers for Medicare and Medicaid Services. Merger and acquisition activity took a hit, but investors haven’t left this sector completely. Valuations are still high, however, as population management and coordinated care initiatives have become a focus of healthcare policy makers, providers and payors. Join us as our panel discusses recent trends in M&A, reimbursement and other topics.

In this session, you will learn: